| BvFTD patients (n = 33) | Controls (n =33) | Asymptomatic MAPT carriers (n = 6) | Noncarriers in the family (n = 12) | P-value bvFTD patients vs controls | P-value MAPT carriers vs noncarriers |
---|---|---|---|---|---|---|
Age | 58.94 ± 9.87 | 55.82±10.05 | 49.00 ± 3.90 | 42.25 ± 9.21 | 0.20a | 0.11a |
Sex (male/female) | 16/17 | 15/18 | 3/3 | 7/5 | 0.99c | 0.99c |
Years of education | 10.62 ± 4.64 | 11.31 ±3.47 | 8.67 ± 0.52 | 10.55 ± 3.80 | 0.52a | 0.25a |
MMSE | 16.52 ± 6.87 | 28.65 ± 2.07 | 28.67 ± 0.82 | 28.36 ± 2.06 | <0.0001b | 0.74a |
MoCA | 10.15 ± 6.25 | 26.06 ± 3.43 | 26.50 ± 1.23 | 26.18 ± 3.06 | <0.0001b | 0.81a |
FTLD-CDR | 10.98 ± 4.46 | 0 ± 0 | 0 ± 0 | 0 ± 0 | <0.0001b | - |
Memory | ||||||
 AVLT: immediate recall | 7.70 ± 7.38 | 23.81 ± 5.59 | 23.83 ± 2.32 | 26.00 ± 7.32 | <0.0001a | 0.50a |
 AVLT: delayed recall | 1.35 ± 2.53 | 8.79 ± 2.98 | 8.67 ± 2.25 | 9.27 ± 3.16 | <0.0001a | 0.69a |
Executive function | ||||||
 TMT-A | 111.60±39.95 | 50.48 ± 24.94 | 44.33 ± 14.98 | 42.00 ±18.75 | <0.0001b | 0.79a |
 TMT-B | 247.80±82.95 | 88.44 ± 62.59 | 85.17 ± 35.37 | 63.67±31.04 | <0.0001a | 0.19a |
Language | ||||||
 BNT | 11.63 ± 6.39 | 24.96 ± 3.83 | 25.00 ± 1.00 | 24.90 ± 2.08 | <0.0001b | 0.92a |
Behavior features | ||||||
 FBI total score | 26.87 ± 14.94 | 1.67 ± 4.08 | 0 (0–6) | 0 (0–2) | <0.0001b | 0.84b |
 FBI apathy | 17.58 ± 9.02 | 0.83 ± 2.04 | 0 (0–4) | 0 (0–0) | <0.0001b | 0.40b |
 FBI disinhibition | 9.29 ± 7.88 | 0.83 ± 2.04 | 0 (0–2) | 0 (0–1.5) | <0.001b | 0.99b |